286 related articles for article (PubMed ID: 498111)
21. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
Fisher B; Gunduz N
J Natl Cancer Inst; 1979 Jun; 62(6):1545-51. PubMed ID: 286125
[No Abstract] [Full Text] [Related]
22. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
[TBL] [Abstract][Full Text] [Related]
24. Response of tumors to biologic modifiers and chemotherapeutic agents.
Katsuoka Y; deKernion JB
Tokai J Exp Clin Med; 1983 May; 8(2):175-85. PubMed ID: 6658848
[TBL] [Abstract][Full Text] [Related]
25. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
[TBL] [Abstract][Full Text] [Related]
26. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors.
Fisher B; Linta J; Hanlon J; Saffer E
J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929
[No Abstract] [Full Text] [Related]
27. Effects of methanol extraction residue and therapeutic irradiation against established isografts and simulated local recurrence of mammary carcinomas.
Yron I; Cohen D; Robinson E; Haber M; Weiss DW
Cancer Res; 1975 Jul; 35(7):1779-90. PubMed ID: 1093676
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
29. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
30. Effect of glucan and other adjuvants on the clearance of radiolabeled tumor cells from mouse lungs.
Proctor JW; Stiteler RD; Yamamura Y; Mansell PW; Winters R
Cancer Treat Rep; 1978 Nov; 62(11):1873-80. PubMed ID: 728905
[TBL] [Abstract][Full Text] [Related]
31. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
32. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
Lichtenstein AK; Berek J; Kahle J; Zighelboim J
Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
[TBL] [Abstract][Full Text] [Related]
33. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
34. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
Fisher B; Wolmark N; Saffer E; Fisher ER
Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
[TBL] [Abstract][Full Text] [Related]
36. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
Gebhardt MC; Fisher B
J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
[No Abstract] [Full Text] [Related]
37. Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
Ibraheim EH; El Kappany H; Nigam VN; Brailovsky CA; Madarnas P; Elhilali MM
Anticancer Res; 1984; 4(3):209-13. PubMed ID: 6465859
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity to chemotherapeutic and immunomodulating agents of two mouse lymphomas and of a macrophage tumor.
Tarnowski GS; Ralph P; Stock CC
Cancer Res; 1979 Oct; 39(10):3964-7. PubMed ID: 476634
[TBL] [Abstract][Full Text] [Related]
39. Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.
Li LH; Johnson MA; Moeller RB; Wallace TL
Cancer Res; 1984 Jul; 44(7):2841-7. PubMed ID: 6722813
[TBL] [Abstract][Full Text] [Related]
40. Proceedings: The effect of Bacille Calmette-Guérin (BCG) and Corynebacterium parvum on the development of spontaneous mouse mammary carcinoma.
Simpson JS; Clark AW
Br J Surg; 1976 Feb; 63(2):152-3. PubMed ID: 766891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
